NOV 28, 2016 5:23 PM PST

Using Stem Cells to Understand Aging & Fight Neurodegeneration

WRITTEN BY: Carmen Leitch
An organism is dependent on the replenishment and maintenance of cellular proteins in order to survive. One family of proteins, chaperones, is responsible for protein quality control in a cell and aids in the folding of proteins into their proper three-dimensional structure. As organisms age, that ability is among those that degenerate, the result is a buildup of proteins of low quality – those that are damaged or misfolded and can cause cellular dysfunction and death. The accumulation of dysfunctional proteins, and a decline in the quality of proteins is seen as a hallmark of aging has been linked to neurodegenerative disorders like Huntington’s, Parkinson’s and Alzheimer’s diseases.
 
Long-lived germline-lacking C. elegans exhibit up-regulation of CCT expression in somatic tissues. Representative image of GFP expressed under control of the cct-8 promoter in adult wild-type and germline-lacking (glp-1(e2141)) worms. DAPI. / Credit: Alireza Noormohammadi and Amirabbas Khodakarami
 
Human pluripotent stem cells have the unique ability to continue to replicate, while remain undifferentiated – open to become any cell type and not specified to a certain type of cell. They are thus immortal, and while in that state, they are able to maintain critical balances in their protein content. That makes them a prime candidate for the investigation of how protein maintenance melds with aging.
 
Reporting in Nature Communications, researchers analyzed the mechanisms of global protein level maintenance in stem cells. "There is one chaperone system, the TRiC/CCT-complex that is responsible for folding about 10% of all the cellular proteins. By studying how pluripotent stem cells maintain the quality of their proteome, we found that this complex is regulated by the subunit CCT8," said the senior author of the study, David Vilchez.
 
That data enabled them to investigate the mechanism in a live organism – the roundworm. "Then, we discovered a way to increase the assembly and activity of the TRiC/CCT complex in somatic tissues by modulating this single subunit, CCT8. The increase resulted in prolonged lifespan and delay of age-related diseases of the model organism Caenorhabditis elegans," Vilchez explained.
 
"For this study we combined the results from human pluripotent stem cells and C. elegans, to have both in vitro and in vivo models, providing a more convincing approach. Our results show that expressing CCT8 as the key subunit of the complex is sufficient to boost the assembly of the whole system," said study first author Alireza Noormohammadi.
 
"It is very interesting that expressing this single subunit is enough to enhance protein quality and extend longevity, even in older animals," added Amirabbas Khodakarami, another study author.
 
"One of our next steps will be to test our findings in mice," said Vilchez. "We hope to make further progress in understanding aging diseases and to get closer to finding therapies against diseases like Huntington's or Alzheimer's. CCT8 could be a candidate to correct deficiencies in age-related diseases associated with protein dysfunctions."
 

 If you want to know more about misfolded proteins and their impact on human health, check out the short video above from the Penn Institute on Aging.
 
Sources: Phys.org via University of Cologne, Genes & Development, Nature Communications
 
About the Author
BS
Experienced research scientist and technical expert with authorships on over 30 peer-reviewed publications, traveler to over 70 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
SEP 26, 2022
Immunology
A Rheumatoid Arthritis-Promoting Molecule is Identified
SEP 26, 2022
A Rheumatoid Arthritis-Promoting Molecule is Identified
Researchers have found that a protein called sulfatase-2 may play a significant role in the tissue damage caused by rheu ...
SEP 29, 2022
Cancer
Customer-Led Innovation: Building the CTS Xenon
SEP 29, 2022
Customer-Led Innovation: Building the CTS Xenon
How customers and R&D scientists came together across oceans and a pandemic to create a next-gen cell therapy soluti ...
SEP 26, 2022
Cancer
Clinical Trial Suggests Oncolytic Virus Effective in Combination with Immune Checkpoint Inhibition
SEP 26, 2022
Clinical Trial Suggests Oncolytic Virus Effective in Combination with Immune Checkpoint Inhibition
One type of cancer immunotherapy, called oncolytic viral therapy, works by infecting cancer cells with a specific virus. ...
OCT 05, 2022
Cell & Molecular Biology
Researchers Discover Muscle Disease Starts Earlier Than Thought
OCT 05, 2022
Researchers Discover Muscle Disease Starts Earlier Than Thought
People with Duchenne muscular dystrophy (DMD) start to experience symptoms in early childhood. The disease is caused by ...
OCT 21, 2022
Immunology
Researchers Find Cause of Flares in Rare Autoinflammatory Disease
OCT 21, 2022
Researchers Find Cause of Flares in Rare Autoinflammatory Disease
Mevalonate kinase deficiency (MKD) is a rare genetic disease caused by mutations in the mevalonate kinase gene, which en ...
NOV 14, 2022
Drug Discovery & Development
Experimental Opioid Vaccine Could Prevent Overdose Deaths
NOV 14, 2022
Experimental Opioid Vaccine Could Prevent Overdose Deaths
Researchers have developed a vaccine that may be able to block the opioid fentanyl from reaching the brain. They note th ...
Loading Comments...